CLARITY MEDICAL (01406) Appoints Forensic Advisor to Investigate Alleged Misstatements

Bulletin Express03-05

Clarity Medical Group Holding Limited (the “Company”) provided an update on its ongoing resumption process following announcements dated 30 May 2025, 30 June 2025, and 14 January 2026. The Company is required under the Stock Exchange’s Resumption Guidance to conduct an independent forensic investigation into allegations of material misstatements in its Prospectus, assess potential impacts on business operations and financial position, and take appropriate remedial actions.

The Board approved the Separate Special Committee’s recommendation to appoint Grant Thornton Advisory Services Limited as the forensic advisor. Grant Thornton Advisory Services Limited will examine the relevant allegations and present findings to the Separate Special Committee and the Board. The Company intends to release further announcements on the investigation and any resulting actions.

Trading of the Company’s shares has been suspended since 15 April 2025, and this suspension remains in effect until further notice. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1172402231?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-05 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1172402231","market":"us","top_or_hot":-1,"title":"CLARITY MEDICAL (01406) Appoints Forensic Advisor to Investigate Alleged Misstatements","media":"Bulletin Express","content":"<p>Clarity Medical Group Holding Limited (the “Company”) provided an update on its ongoing resumption process following announcements dated 30 May 2025, 30 June 2025, and 14 January 2026. The Company is required under the Stock Exchange’s Resumption Guidance to conduct an independent forensic investigation into allegations of material misstatements in its Prospectus, assess potential impacts on business operations and financial position, and take appropriate remedial actions.</p>\n<p>The Board approved the Separate Special Committee’s recommendation to appoint Grant Thornton Advisory Services Limited as the forensic advisor. Grant Thornton Advisory Services Limited will examine the relevant allegations and present findings to the Separate Special Committee and the Board. The Company intends to release further announcements on the investigation and any resulting actions.</p>\n<p>Trading of the Company’s shares has been suspended since 15 April 2025, and this suspension remains in effect until further notice. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>CLARITY MEDICAL (01406) Appoints Forensic Advisor to Investigate Alleged Misstatements</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCLARITY MEDICAL (01406) Appoints Forensic Advisor to Investigate Alleged Misstatements\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-03-05 20:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Clarity Medical Group Holding Limited (the “Company”) provided an update on its ongoing resumption process following announcements dated 30 May 2025, 30 June 2025, and 14 January 2026. The Company is required under the Stock Exchange’s Resumption Guidance to conduct an independent forensic investigation into allegations of material misstatements in its Prospectus, assess potential impacts on business operations and financial position, and take appropriate remedial actions.</p>\n<p>The Board approved the Separate Special Committee’s recommendation to appoint Grant Thornton Advisory Services Limited as the forensic advisor. Grant Thornton Advisory Services Limited will examine the relevant allegations and present findings to the Separate Special Committee and the Board. The Company intends to release further announcements on the investigation and any resulting actions.</p>\n<p>Trading of the Company’s shares has been suspended since 15 April 2025, and this suspension remains in effect until further notice. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"01406","symbol_name":"清晰医疗","start_time":0,"source_url":"","article_id":"1172402231","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1172402231","pubTimestamp":1772712189,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Clarity Medical Group Holding Limited (the “Company”) provided an update on its ongoing resumption process following announcements dated 30 May 2025, 30 June 2025, and 14 January 2026. The Company is...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"01406":"清晰医疗"},"translate_title":"CLARITY MEDICAL(01406)委任法证顾问调查涉嫌失实陈述","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01406":1},"content_text":"Clarity Medical Group Holding Limited (the “Company”) provided an update on its ongoing resumption process following announcements dated 30 May 2025, 30 June 2025, and 14 January 2026. The Company is required under the Stock Exchange’s Resumption Guidance to conduct an independent forensic investigation into allegations of material misstatements in its Prospectus, assess potential impacts on business operations and financial position, and take appropriate remedial actions.\nThe Board approved the Separate Special Committee’s recommendation to appoint Grant Thornton Advisory Services Limited as the forensic advisor. Grant Thornton Advisory Services Limited will examine the relevant allegations and present findings to the Separate Special Committee and the Board. The Company intends to release further announcements on the investigation and any resulting actions.\nTrading of the Company’s shares has been suspended since 15 April 2025, and this suspension remains in effect until further notice. Shareholders and potential investors are urged to exercise caution when dealing in the Company’s securities.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.38.0","shortVersion":"4.38.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1172402231","isCrawlerRequest":true}